SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

2 Hot Dogs or 1 Large Cookie? A Study of Risks by Amount of Ultraprocessed Food

— Mounting observational evidence links ultraprocessed food with heart disease, cancer, death

Stem Cell Infusion Cut Fractures; Testosterone for Menopause; BMD and Cognition

— News and commentary from the endocrinology world

GLP-1 Lawsuits Over Eye Risk; Hospital Oxygen Supply Cut; Top Causes of U.S. Deaths

Health news and commentary gathered by MedPage Today staff

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Thyroid Meds Recalled Nationwide; Life Expectancy Rebounds; Cannabis Use Hits Record

Health news and commentary gathered by MedPage Today staff

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Latest News

— Mounting observational evidence links ultraprocessed food with heart disease, cancer, death

— News and commentary from the endocrinology world

Health news and commentary gathered by MedPage Today staff

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Health news and commentary gathered by MedPage Today staff

News All Time

Pesticide Found in Supplement; Brain-Eating Amoeba Kills Teen; B12 and Birth Defects

Health news and commentary gathered by MedPage Today staff

ADA Says Booted Meeting Attendees Violated Code of Conduct

Expelled researchers unhappy with conclusion of organization's review

Off-Label GLP-1 Use Skyrockets in Young Kids

Weight-loss formulations are only approved for kids 12 years and older

Endometriosis Can Elude Diagnosis for Years. What to Know About New Ways to Find It.

New tests available abroad are raising hope among doctors and patients

New GLP-1 Hair Loss Insights; Wegovy in Kids; Are Fitness Trackers Lying to Users?

News and commentary from the endocrinology world

Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek

TIMBERLINE study shows good safety and sweat chloride reductions with triple combo CFTR modulator

Menopausal Hormone Therapy May Ease Severe Mood Symptoms

Therapy also associated with better sleep scores in non-controlled study

The CDC Division I Spent 15 Years Building Is in Peril

Cuts to the Division of Nutrition, Physical Activity, and Obesity will not make America healthy

The Market Forces Quietly Adding Thousands to Patient Bills

A look at a shifting industry

Preserving Muscle During GLP-1 Weight Loss

Experts advise tracking body composition, boosting protein, and resistance training

Early T1D Screening Guide; FDA Clears Mint Patch Pump; GLP-1s and Fertility

News and commentary from the endocrinology world

ADA Boycott Follows Meeting Scandal; Lawsuits Fly in Residency Application Space

MedPage Today reporters offer further insights into recently covered topics

Pentagon Revives Testosterone Testing After Pause, Excludes Women

The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among US service members age 30 and older, a spokesperson ⁠said on Thursday, bringing...

Osteoporosis: Are Bone Density Targets Worth Chasing?

Specialists debate the value of specific bone density goals with concerns that measurement variability and limited trial evidence may complicate treatment decisions.

GLP-1 Systematic Review Finds Weight Loss of Up to 24%

GLP-1 drugs are associated with substantial weight loss in adults without diabetes, and the range of options, including oral and multiagonist therapies, is expanding.

Nurse-Led Digital Therapeutics Boosts Diabetes Outcomes

A structured nurse-led digital therapeutics pathway is linked to higher adherence and more favorable metabolic outcomes than usual care in adults with type 2 diabetes, a study reports.

Recommended News For You

Ineffective medication can remove the "worst fear" of schizophrenia.

Hypnotherapy may offer real benefits for cancer patient care

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Asian Women With Breast Cancer Outlive White Peers

November 2023, Medical Bulletin 04/.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

Recommended Articles For You

Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review 

Liquid Biopsies in Hematology: A Window into the Disease 

Federated Hematology Data Networks for Collaborative Research Without Centralized Patient-Level Data 

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

2.

Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.

3.

Stevia leaf extract has potential as anticancer treatment, researchers find

4.

Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation

5.

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

1.

Strategic Applications in Hematology in Clinical Decision-Making

2.

The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond

3.

Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications

4.

Pathophysiology of Tumor Cell Extracellular Matrix Remodeling

5.

Building Physical Resilience in Chronic Blood Disorders

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Early Cancer Detection Saves Lives

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

4.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

5.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot